Insights Resources Tutorials Bioanalysis of Oligonucleotide Therapeutics By Laixin Wang, PhD January 15, 2011 January 15, 2011 (Vol. 31, No. 2) LC-MS/MS Allows for Accurate and Sensitive HT ...

Optimizing LC-MS/MS Conditions We are interested in accurately quantifying small oligonucleotide therapeutics in bodily fluids such as plasma. Here we randomly chose an 18-mer phosphorothioate ...

The workshop will introduce chromatographic challenges associated with large molecules and bioanalytical troubleshooting for biotherapeutics through a combination of lectures and worked examples. At ...

In bioanalysis, AI could help streamline routine processes and alleviate the processing and analyzing of preclinical and clinical bioanalytical data. While promising, AI comes with unique challenges ...

Dash's Fully Automated Bioanalysis Platform Is Reshaping Drug Development with Speed, Precision, and Scale. NEWTON, Mass., ...

The box in front of me is unremarkable aside from a few wires sprouting from it, but it is apparently about to give me a full body check (‘bioanalysis’) via methods I don’t understand (‘quantum’).

The significance of oligonucleotides (OGNTs) in drug development is increasing rapidly, as they offer promising and life-changing treatments that can improve patients' lives. Within bioanalysis, there ...

Get to know 2025 Diversity in Business honoree Lake Paul, founder and CEO of BioAnalysis.

Why local biotech firm BioAnalysis is feeling right at home in Kensington, Philly’s most beleaguered neighborhood ...